Global and China Respiratory Drugs Market Insights, Forecast to 2027

Publisher Name :
Date: 25-Aug-2021
No. of pages: 130
Inquire Before Buying

Respiratory Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Respiratory Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Asthma

- Chronic Obstructive Pulmonary Disease

- Idiopathic Pulmonary Fibrosis

- Cystic Fibrosis

Segment by Application

- Hospitals

- Ambulatory Care

- Others

By Region

- North America

- - United States

- - Canada

- - Mexico

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- FibroGen

- Amgen

- Dr. Reddy's Laboratories

- Afferent Pharmaceuticals

- Dainippon Sumitomo

- Abbott

- Horizon Pharma

- Amgen

- Pfizer

Global and China Respiratory Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Respiratory Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Drugs Market Size Growth Rate by Type
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease
1.2.4 Idiopathic Pulmonary Fibrosis
1.2.5 Cystic Fibrosis
1.3 Market by Application
1.3.1 Global Respiratory Drugs Market Size Growth Rate by Application
1.3.2 Hospitals
1.3.3 Ambulatory Care
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Respiratory Drugs Market Size, Estimates and Forecasts
2.1.1 Global Respiratory Drugs Revenue 2016-2027
2.1.2 Global Respiratory Drugs Sales 2016-2027
2.2 Global Respiratory Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Respiratory Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Respiratory Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Respiratory Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Respiratory Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Respiratory Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Respiratory Drugs Revenue Forecast by Region (2022-2027)
3 Global Respiratory Drugs Competitor Landscape by Players
3.1 Global Top Respiratory Drugs Manufacturers by Sales
3.1.1 Global Respiratory Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Respiratory Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Respiratory Drugs Manufacturers by Revenue
3.2.1 Key Respiratory Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Respiratory Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Respiratory Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Respiratory Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Respiratory Drugs Revenue in 2020
3.2.6 Global Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Respiratory Drugs Price by Manufacturers
3.4 Global Respiratory Drugs Manufacturing Base Distribution, Product Types
3.4.1 Respiratory Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Respiratory Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Respiratory Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Respiratory Drugs Market Size by Type (2016-2021)
4.1.1 Global Respiratory Drugs Sales by Type (2016-2021)
4.1.2 Global Respiratory Drugs Revenue by Type (2016-2021)
4.1.3 Respiratory Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Respiratory Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Respiratory Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Respiratory Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Respiratory Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Respiratory Drugs Market Size by Application (2016-2021)
5.1.1 Global Respiratory Drugs Sales by Application (2016-2021)
5.1.2 Global Respiratory Drugs Revenue by Application (2016-2021)
5.1.3 Respiratory Drugs Price by Application (2016-2021)
5.2 Respiratory Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Respiratory Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Respiratory Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Respiratory Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Respiratory Drugs Market Size YoY Growth 2016-2027
6.1.1 China Respiratory Drugs Sales YoY Growth 2016-2027
6.1.2 China Respiratory Drugs Revenue YoY Growth 2016-2027
6.1.3 China Respiratory Drugs Market Share in Global Market 2016-2027
6.2 China Respiratory Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Respiratory Drugs Players by Sales (2016-2021)
6.2.2 China Top Respiratory Drugs Players by Revenue (2016-2021)
6.3 China Respiratory Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Respiratory Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Respiratory Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Respiratory Drugs Price by Type (2016-2021)
6.4 China Respiratory Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Respiratory Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Respiratory Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Respiratory Drugs Price Forecast by Type (2022-2027)
6.5 China Respiratory Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Respiratory Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Respiratory Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Respiratory Drugs Price by Application (2016-2021)
6.6 China Respiratory Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Respiratory Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Respiratory Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Respiratory Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Respiratory Drugs Market Size YoY Growth 2016-2027
7.2 North America Respiratory Drugs Market Facts & Figures by Country
7.2.1 North America Respiratory Drugs Sales by Country (2016-2021)
7.2.2 North America Respiratory Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
7.2.5 Mexico
8 Asia Pacific
8.1 Asia Pacific Respiratory Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Respiratory Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Respiratory Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Respiratory Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Thailand
8.2.10 Malaysia
8.2.11 Philippines
8.2.12 Vietnam
9 Europe
9.1 Europe Respiratory Drugs Market Size YoY Growth 2016-2027
9.2 Europe Respiratory Drugs Market Facts & Figures by Country
9.2.1 Europe Respiratory Drugs Sales by Country (2016-2021)
9.2.2 Europe Respiratory Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 UK
9.2.6 Italy
10 Latin America
10.1 Latin America Respiratory Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Respiratory Drugs Market Facts & Figures by Country
10.2.1 Latin America Respiratory Drugs Sales by Country (2016-2021)
10.2.2 Latin America Respiratory Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Respiratory Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Respiratory Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Respiratory Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Respiratory Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 FibroGen
12.1.1 FibroGen Corporation Information
12.1.2 FibroGen Description and Business Overview
12.1.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 FibroGen Respiratory Drugs Products Offered
12.1.5 FibroGen Recent Development
12.2 Amgen
12.2.1 Amgen Corporation Information
12.2.2 Amgen Description and Business Overview
12.2.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Amgen Respiratory Drugs Products Offered
12.2.5 Amgen Recent Development
12.3 Dr. Reddy's Laboratories
12.3.1 Dr. Reddy's Laboratories Corporation Information
12.3.2 Dr. Reddy's Laboratories Description and Business Overview
12.3.3 Dr. Reddy's Laboratories Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Dr. Reddy's Laboratories Respiratory Drugs Products Offered
12.3.5 Dr. Reddy's Laboratories Recent Development
12.4 Afferent Pharmaceuticals
12.4.1 Afferent Pharmaceuticals Corporation Information
12.4.2 Afferent Pharmaceuticals Description and Business Overview
12.4.3 Afferent Pharmaceuticals Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Afferent Pharmaceuticals Respiratory Drugs Products Offered
12.4.5 Afferent Pharmaceuticals Recent Development
12.5 Dainippon Sumitomo
12.5.1 Dainippon Sumitomo Corporation Information
12.5.2 Dainippon Sumitomo Description and Business Overview
12.5.3 Dainippon Sumitomo Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Dainippon Sumitomo Respiratory Drugs Products Offered
12.5.5 Dainippon Sumitomo Recent Development
12.6 Abbott
12.6.1 Abbott Corporation Information
12.6.2 Abbott Description and Business Overview
12.6.3 Abbott Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Abbott Respiratory Drugs Products Offered
12.6.5 Abbott Recent Development
12.7 Horizon Pharma
12.7.1 Horizon Pharma Corporation Information
12.7.2 Horizon Pharma Description and Business Overview
12.7.3 Horizon Pharma Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Horizon Pharma Respiratory Drugs Products Offered
12.7.5 Horizon Pharma Recent Development
12.8 Amgen
12.8.1 Amgen Corporation Information
12.8.2 Amgen Description and Business Overview
12.8.3 Amgen Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Amgen Respiratory Drugs Products Offered
12.8.5 Amgen Recent Development
12.9 Pfizer
12.9.1 Pfizer Corporation Information
12.9.2 Pfizer Description and Business Overview
12.9.3 Pfizer Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Pfizer Respiratory Drugs Products Offered
12.9.5 Pfizer Recent Development
12.11 FibroGen
12.11.1 FibroGen Corporation Information
12.11.2 FibroGen Description and Business Overview
12.11.3 FibroGen Respiratory Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 FibroGen Respiratory Drugs Products Offered
12.11.5 FibroGen Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Respiratory Drugs Industry Trends
13.2 Respiratory Drugs Market Drivers
13.3 Respiratory Drugs Market Challenges
13.4 Respiratory Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Respiratory Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Respiratory Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Asthma
Table 3. Major Manufacturers of Chronic Obstructive Pulmonary Disease
Table 4. Major Manufacturers of Idiopathic Pulmonary Fibrosis
Table 5. Major Manufacturers of Cystic Fibrosis
Table 6. Global Respiratory Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 7. Global Respiratory Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 8. Global Respiratory Drugs Sales by Regions (2016-2021) & (K Units)
Table 9. Global Respiratory Drugs Sales Market Share by Regions (2016-2021)
Table 10. Global Respiratory Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 11. Global Respiratory Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 12. Global Respiratory Drugs Sales Market Share Forecast by Region (2022-2027)
Table 13. Global Respiratory Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 14. Global Respiratory Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 15. Global Respiratory Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 16. Global Respiratory Drugs Sales Share by Manufacturers (2016-2021)
Table 17. Ranking of Global Top Respiratory Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 18. Respiratory Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 19. Respiratory Drugs Revenue Share by Manufacturers (2016-2021)
Table 20. Global Respiratory Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 21. Global Respiratory Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drugs as of 2020)
Table 22. Key Manufacturers Respiratory Drugs Price (2016-2021) (USD/Unit)
Table 23. Respiratory Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Respiratory Drugs Product Type
Table 25. Date of International Manufacturers Enter into Respiratory Drugs Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Respiratory Drugs Sales by Type (2016-2021) (K Units)
Table 28. Global Respiratory Drugs Sales Share by Type (2016-2021)
Table 29. Global Respiratory Drugs Revenue by Type (2016-2021) (US$ Million)
Table 30. Global Respiratory Drugs Revenue Share by Type (2016-2021)
Table 31. Respiratory Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 32. Global Respiratory Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 33. Global Respiratory Drugs Sales Market Share Forecast by Type (2022-2027)
Table 34. Global Respiratory Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 35. Global Respiratory Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 36. Global Respiratory Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 37. Global Respiratory Drugs Sales by Application (2016-2021) (K Units)
Table 38. Global Respiratory Drugs Sales Share by Application (2016-2021)
Table 39. Global Respiratory Drugs Revenue by Application (2016-2021) (US$ Million)
Table 40. Global Respiratory Drugs Revenue Share by Application (2016-2021)
Table 41. Respiratory Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 42. Global Respiratory Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 43. Global Respiratory Drugs Sales Market Share Forecast by Application (2022-2027)
Table 44. Global Respiratory Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 45. Global Respiratory Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 46. Global Respiratory Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 47. China Respiratory Drugs Sales (K Units) of Key Companies (2016-2021)
Table 48. China Respiratory Drugs Sales Share by Company (2016-2021)
Table 49. China Respiratory Drugs Revenue (US$ Million) by Company (2016-2021)
Table 50. China Respiratory Drugs Revenue Share by Company (2016-2021)
Table 51. China Respiratory Drugs Sales (K Units) by Type (2016-2021)
Table 52. China Respiratory Drugs Sales Share by Type (2016-2021)
Table 53. China Respiratory Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 54. China Respiratory Drugs Price (USD/Unit) by Type (2016-2021)
Table 55. China Respiratory Drugs Sales (K Units) by Type (2022-2027)
Table 56. China Respiratory Drugs Sales Share by Type (2022-2027)
Table 57. China Respiratory Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 58. China Respiratory Drugs Revenue Share by Type (2022-2027)
Table 59. China Respiratory Drugs Price (USD/Unit) by Type (2022-2027)
Table 60. China Respiratory Drugs Sales (K Units) by Application (2016-2021)
Table 61. China Respiratory Drugs Sales Share by Application (2016-2021)
Table 62. China Respiratory Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 63. China Respiratory Drugs Price (USD/Unit) by Application (2016-2021)
Table 64. China Respiratory Drugs Sales (K Units) by Application (2022-2027)
Table 65. China Respiratory Drugs Sales Share by Application (2022-2027)
Table 66. China Respiratory Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 67. China Respiratory Drugs Revenue Share by Application (2022-2027)
Table 68. China Respiratory Drugs Price (USD/Unit) by Application (2022-2027)
Table 69. North America Respiratory Drugs Sales by Country (2016-2021) & (K Units)
Table 70. North America Respiratory Drugs Sales Market Share by Country (2016-2021)
Table 71. North America Respiratory Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 72. North America Respiratory Drugs Revenue Market Share by Country (2016-2021)
Table 73. Asia Pacific Respiratory Drugs Sales by Region (2016-2021) & (K Units)
Table 74. Asia Pacific Respiratory Drugs Sales Market Share by Region (2016-2021)
Table 75. Asia Pacific Respiratory Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 76. Asia Pacific Respiratory Drugs Revenue Market Share by Region (2016-2021)
Table 77. Europe Respiratory Drugs Sales by Country (2016-2021) & (K Units)
Table 78. Europe Respiratory Drugs Sales Market Share by Country (2016-2021)
Table 79. Europe Respiratory Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 80. Europe Respiratory Drugs Revenue Market Share by Country (2016-2021)
Table 81. Latin America Respiratory Drugs Sales by Country (2016-2021) & (K Units)
Table 82. Latin America Respiratory Drugs Sales Market Share by Country (2016-2021)
Table 83. Latin Americaa Respiratory Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 84. Latin America Respiratory Drugs Revenue Market Share by Country (2016-2021)
Table 85. Middle East and Africa Respiratory Drugs Sales by Country (2016-2021) & (K Units)
Table 86. Middle East and Africa Respiratory Drugs Sales Market Share by Country (2016-2021)
Table 87. Middle East and Africa Respiratory Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 88. Middle East and Africa Respiratory Drugs Revenue Market Share by Country (2016-2021)
Table 89. FibroGen Corporation Information
Table 90. FibroGen Description and Business Overview
Table 91. FibroGen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 92. FibroGen Respiratory Drugs Product
Table 93. FibroGen Recent Development
Table 94. Amgen Corporation Information
Table 95. Amgen Description and Business Overview
Table 96. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 97. Amgen Product
Table 98. Amgen Recent Development
Table 99. Dr. Reddy's Laboratories Corporation Information
Table 100. Dr. Reddy's Laboratories Description and Business Overview
Table 101. Dr. Reddy's Laboratories Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 102. Dr. Reddy's Laboratories Product
Table 103. Dr. Reddy's Laboratories Recent Development
Table 104. Afferent Pharmaceuticals Corporation Information
Table 105. Afferent Pharmaceuticals Description and Business Overview
Table 106. Afferent Pharmaceuticals Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 107. Afferent Pharmaceuticals Product
Table 108. Afferent Pharmaceuticals Recent Development
Table 109. Dainippon Sumitomo Corporation Information
Table 110. Dainippon Sumitomo Description and Business Overview
Table 111. Dainippon Sumitomo Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 112. Dainippon Sumitomo Product
Table 113. Dainippon Sumitomo Recent Development
Table 114. Abbott Corporation Information
Table 115. Abbott Description and Business Overview
Table 116. Abbott Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 117. Abbott Product
Table 118. Abbott Recent Development
Table 119. Horizon Pharma Corporation Information
Table 120. Horizon Pharma Description and Business Overview
Table 121. Horizon Pharma Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 122. Horizon Pharma Product
Table 123. Horizon Pharma Recent Development
Table 124. Amgen Corporation Information
Table 125. Amgen Description and Business Overview
Table 126. Amgen Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 127. Amgen Product
Table 128. Amgen Recent Development
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Business Overview
Table 131. Pfizer Respiratory Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 132. Pfizer Product
Table 133. Pfizer Recent Development
Table 134. Respiratory Drugs Market Trends
Table 135. Respiratory Drugs Market Drivers
Table 136. Respiratory Drugs Market Challenges
Table 137. Respiratory Drugs Market Restraints
Table 138. Respiratory Drugs Customers List
Table 139. Respiratory Drugs Distributors List
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Drugs Product Picture
Figure 2. Global Respiratory Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Asthma Product Picture
Figure 4. Chronic Obstructive Pulmonary Disease Product Picture
Figure 5. Idiopathic Pulmonary Fibrosis Product Picture
Figure 6. Cystic Fibrosis Product Picture
Figure 7. Global Respiratory Drugs Sales Market Share by Application in 2020 & 2027
Figure 8. Hospitals
Figure 9. Ambulatory Care
Figure 10. Others
Figure 11. Respiratory Drugs Report Years Considered
Figure 12. Global Respiratory Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Respiratory Drugs Market Size 2016-2027 (US$ Million)
Figure 14. Global Respiratory Drugs Sales 2016-2027 (K Units)
Figure 15. Global Respiratory Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 16. Global Respiratory Drugs Sales Market Share by Region (2016-2021)
Figure 17. Global Respiratory Drugs Sales Market Share by Region in 2020
Figure 18. Global Respiratory Drugs Revenue Market Share by Region (2016-2021)
Figure 19. Global Respiratory Drugs Revenue Market Share by Region in 2020
Figure 20. Global Respiratory Drugs Sales Share by Manufacturer in 2020
Figure 21. The Top 10 and 5 Players Market Share by Respiratory Drugs Revenue in 2020
Figure 22. Respiratory Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 23. Global Respiratory Drugs Sales Market Share by Type (2016-2021)
Figure 24. Global Respiratory Drugs Sales Market Share by Type in 2020
Figure 25. Global Respiratory Drugs Revenue Market Share by Type (2016-2021)
Figure 26. Global Respiratory Drugs Revenue Market Share by Type in 2020
Figure 27. Global Respiratory Drugs Sales Market Share by Application (2016-2021)
Figure 28. Global Respiratory Drugs Sales Market Share by Application in 2020
Figure 29. Global Respiratory Drugs Revenue Market Share by Application (2016-2021)
Figure 30. Global Respiratory Drugs Revenue Market Share by Application in 2020
Figure 31. China Respiratory Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 32. China Respiratory Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 33. China Respiratory Drugs Market Share in Global Market 2016-2027
Figure 34. China 5 and 10 Largest Respiratory Drugs Players Market Share by Revenue in Respiratory Drugs in 2020
Figure 35. China Respiratory Drugs Revenue Share by Type (2016-2021)
Figure 36. China Respiratory Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 37. China Respiratory Drugs Revenue Share by Application (2016-2021)
Figure 38. China Respiratory Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 39. North America Respiratory Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 40. North America Respiratory Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 41. North America Respiratory Drugs Sales Market Share by Country in 2020
Figure 42. North America Respiratory Drugs Revenue Market Share by Country in 2020
Figure 43. United States Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 44. United States Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Canada Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 46. Canada Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Mexico Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 48. Mexico Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 49. Europe Respiratory Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 50. Europe Respiratory Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 51. Europe Respiratory Drugs Sales Market Share by Country in 2020
Figure 52. Europe Respiratory Drugs Revenue Market Share by Country in 2020
Figure 53. Germany Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 54. Germany Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. France Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 56. France Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. UK Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 58. UK Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Italy Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 60. Italy Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 61. Russia Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 62. Russia Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 63. Asia Pacific Respiratory Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 64. Asia Pacific Respiratory Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 65. Asia Pacific Respiratory Drugs Sales Market Share by Region in 2020
Figure 66. Asia Pacific Respiratory Drugs Revenue Market Share by Region in 2020
Figure 67. China Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 68. China Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. Japan Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 70. Japan Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. South Korea Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 72. South Korea Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. India Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 74. India Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Australia Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 76. Australia Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Indonesia Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 78. Indonesia Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Thailand Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 80. Thailand Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Malaysia Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 82. Malaysia Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Philippines Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 84. Philippines Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Vietnam Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 86. Vietnam Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 87. Latin America Respiratory Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 88. Latin America Respiratory Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 89. Latin America Respiratory Drugs Sales Market Share by Country in 2020
Figure 90. Latin America Respiratory Drugs Revenue Market Share by Country in 2020
Figure 91. Mexico Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 92. Mexico Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Brazil Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 94. Brazil Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Argentina Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 96. Argentina Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 97. Middle East and Africa Respiratory Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 98. Middle East and Africa Respiratory Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 99. Middle East and Africa Respiratory Drugs Sales Market Share by Country in 2020
Figure 100. Middle East and Africa Respiratory Drugs Revenue Market Share by Country in 2020
Figure 101. Turkey Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 102. Turkey Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. Saudi Arabia Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 104. Saudi Arabia Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. UAE Respiratory Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 106. UAE Respiratory Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 107. Respiratory Drugs Value Chain
Figure 108. Channels of Distribution
Figure 109. Distributors Profiles
Figure 110. Bottom-up and Top-down Approaches for This Report
Figure 111. Data Triangulation
Figure 112. Key Executives Interviewed
  • China Ambroxol Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Ambroxol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Ambroxol Market Segment Percentages, By Type, 2020 (%) - Normal type - Long-acting type China Ambroxol Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Ambroxol Market Segment Percentages, By Application, 2020 (%) - Acute Respiratory Diseases - Chronic Respiratory Diseases Competitor Analysis The report also prov......
  • Global and Japan Bovine Respiratory Disease Treatment Market Size, Status and Forecast 2021-2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 97
    Global Bovine Respiratory Disease Treatment Scope and Market Size Bovine Respiratory Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Respiratory Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the p......
  • United States Ambroxol Market Report & Forecast 2021-2027
    Published: 30-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Ambroxol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Type, 2020 (%) - Normal type - Long-acting type United States Ambroxol Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Application, 2020 (%) - Acute Respiratory Diseases - Chronic Respiratory Diseases Competitor Anal......
  • Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021
    Published: 21-Sep-2021        Price: US 2500 Onwards        Pages: 250
    Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Sleep Apnea . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The rep......
  • Global and China Carbocisteine Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 139
    Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API. Global Carbocisteine key players include Moehs......
  • United States Carbocisteine Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Carbocisteine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Type, 2020 (%) - 0.985 - Above 98.50% United States Carbocisteine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Application, 2020 (%) - Oral Solution - Tablet & Capsule - Others Competitor Analysis......
  • Cystic Fibrosis (CF) - Epidemiology Forecast to 2030
    Published: 31-Aug-2021        Price: US 3995 Onwards        Pages: 41
    Cystic Fibrosis (CF) - Epidemiology Forecast to 2030 Summary Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems. In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct the passageways in the lungs and pancreas (Mayo Clinic, 2021). Mucus build-up and airway blockages in the lungs cause symptoms such as persistent cough, wheezing, inflamed nasal ......
  • Bronchiectasis (Respiratory) - Drugs In Development, 2021
    Published: 30-Aug-2021        Price: US 2000 Onwards        Pages: 123
    Bronchiectasis (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provides an overview of the Bronchiectasis (Respiratory) pipeline landscape.Bronchiectasis is a chronic condition where the walls of the bronchial tubes are permanently damaged. These damage allow bacteria and mucus to build up in lungs. Bronchiectasis is divided into two catego......
  • Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021
    Published: 30-Aug-2021        Price: US 2500 Onwards        Pages: 675
    Chronic Obstructive Pulmonary Disease (COPD) (Respiratory) - Drugs In Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Obstructive Pulmonary Disease - Drugs In Development, 2021, provides an overview of the Chronic Obstructive Pulmonary Disease (Respiratory) pipeline landscape.Chronic obstructive pulmonary disease (COPD) is a group of lung diseases. It is characterized by inability to completely breath......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs